Can we predict how kids with IBD will respond to treatment?

NCT ID NCT03571373

Recruiting now Knowledge-focused Sponsor: Erasmus Medical Center Source: ClinicalTrials.gov ↗

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study follows 1,500 children newly diagnosed with inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, to understand why some respond well to treatments while others develop complications. Researchers will collect medical data and biological samples to identify early predictors of disease course and treatment outcomes. The goal is to improve care and tailor treatments to each child's individual risk.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: This research could help doctors predict which children with IBD will respond to specific treatments or face complications, enabling more personalized care.
What could go wrong: As an observational study, it cannot prove cause and effect. Findings may take years to emerge and may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CROHN DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Crohn disease inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CROHN DISEASE INFLAMMATORY BOWEL DISEASES ULCERATIVE COLITIS

Contacts and locations

Locations

Erasmus MC - Sophia Children's Hospital
RECRUITING

Rotterdam, 3015GD, Netherlands
Royal Hospital London
RECRUITING

London, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.